Vaginal Mesh News: FDA Issues Post Operative Recommendations for Women with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse

(PRWEB) August 04, 2011

On July 13, the U.S. Food and Drug Administration (FDA) updated an advisory on vaginal mesh implants reporting that there is little evidence that the implants improve pelvic organ prolapse and that patients are exposed to a number of risks and complications, which are not rare. According to Ennis & Ennis, P.A., the FDA then issued a Safety Communication, which provided an Overview, a Summary of Adverse Event Reports, a Review of their Literature, a Summary of their Key Findings and Recommendations with regards to these transvaginal mesh devices.

Within in the Safety Communication, the FDA made the following recommendations for women after the surgery:

Related Information:

1. Vaginal Mesh News: Parker Waichman Alonso LLP Supports FDA Proposal to Reclassify Transvaginal Mesh Products for Pelvic Organ Prolapse as High-Risk Medical Devices
2. Vaginal Mesh News: Gilman Law LLP Investigating Potential Lawsuits Stemming from Failed Transvaginal (Vaginal, Pelvic, Prolapse, Surgical) Mesh Devices
3. Vaginal Mesh News: Drs. Moore and Miklos of Atlanta Urogynecology Associates Publish the 1st Article in Worldwide Literature on a New Generation Mesh Procedure for Pelvic Organ Prolapse
4. Vaginal Mesh News: FDA May Toughen the Regulations for Transvaginal Mesh Devices
5. Vaginal Mesh News: Firm Investigates Serious Surgical Mesh Injuries in Women